LB

Lawrence Blatt

Chief Executive Officer

Aligos Therapeutics

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Aligos Therapeutics
Industry
biotechnology
Employees
83.0
Seniority
C suite
Annual Revenue
3945000.0

Technologies

Outlook Microsoft Office 365 Adobe Marketing Cloud Google Tag Manager WordPress.org New Relic Akamai RUM Bootstrap Framework Typekit Google Font API reCAPTCHA Google Analytics Mobile Friendly Remote

Keywords

biotechnology: biological products (no diagnostic substances) health care liver diseases viral diseases biopharmaceutical drug discovery clinical stage medicine development hepatology virology patient outcomes therapeutics metabolic dysfunction capsid assembly modulator oral small molecule chronic hepatitis b mash therapeutic pipeline scientific research clinical trials fda clearance innovative therapies targeted treatment patient-centric drug commercialization drug efficacy biotech pharmacologic properties unmet medical needs increased efficacy healthcare biomedical research pharmaceutical research drug development viral hepatitis liver cancer therapeutic innovation scientific foundation clinical research patient impact investor relations healthcare outcomes drug candidates cro biopharma research & development health technology commercial-stage biotechnology analyst coverage health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans